The Big Business Behind Weight-Loss Drugs: Global Market To Hit $ 150 Billion by 2035
They Burst onto the Scene Four Years AGO and Are Tooking Over the Pharmaceutical World. New GLP-1-Based Drugs Like Ozempic, Wegovy or Zepbound Are Said to Be a Weight-Loss Game Change and Could Drive Big Pharma’s Return for Years to Come. But they come with a hefty price tag, while some 50 to 70 pierient…
